Should Investors Buy ASML Stock Before Oct. 16?

Source The Motley Fool

ASML (NASDAQ: ASML) has told investors it expects a strong year in 2025 while admitting to limited growth in 2024.

*Stock prices used were the afternoon prices of Oct. 5, 2024. The video was published on Oct. 7, 2024.

Should you invest $1,000 in ASML right now?

Before you buy stock in ASML, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and ASML wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $814,364!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of October 7, 2024

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Plötzliche Korrektur an den chinesischen Aktienmärkten: Shanghai Composite verliert 4 %, ChiNext fällt um 7 %. Ist die Erholung vorbei?​Insights - Aufgrund höherer Erwartungen an fiskalische Stimulierungsmaßnahmen in China kam es zu einer plötzlichen Korrektur der zuvor stark gestiegenen chinesischen Vermögenswerte, was zu einer abrupten Stimmungswende auf dem Markt führte.
Author  Mitrade
12 hour ago
​Insights - Aufgrund höherer Erwartungen an fiskalische Stimulierungsmaßnahmen in China kam es zu einer plötzlichen Korrektur der zuvor stark gestiegenen chinesischen Vermögenswerte, was zu einer abrupten Stimmungswende auf dem Markt führte.
placeholder
China Stocks Slide on Weaker Economic RecoveryInsights - Chinese assets, which surged recently on hopes for stronger fiscal stimulus, saw a sharp reversal as market sentiment shifted. On Wednesday, mainland Chinese stocks plunged, with major in
Author  Mitrade
12 hour ago
Insights - Chinese assets, which surged recently on hopes for stronger fiscal stimulus, saw a sharp reversal as market sentiment shifted. On Wednesday, mainland Chinese stocks plunged, with major in
placeholder
After downgrading Amazon, Wells Fargo says buy Microsoft stockInvesting.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
Author  Investing.com
17 hour ago
Investing.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
placeholder
Here’s Why The Dogecoin And Shiba Inu Price Crashed AgainDogecoin and Shiba Inu prices have crashed again following their recent upward trend, which led to significant price gains. These price crashes are primarily due to the current macro environment and market uncertainty, which don’t favor risk assets like these meme coins.
Author  Bitcoinist
17 hour ago
Dogecoin and Shiba Inu prices have crashed again following their recent upward trend, which led to significant price gains. These price crashes are primarily due to the current macro environment and market uncertainty, which don’t favor risk assets like these meme coins.
placeholder
MBX Biosciences earns Buy rating at three investment firmsInvesting.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
Author  Investing.com
17 hour ago
Investing.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
goTop
quote